Home Innovation That Matters

Innovation That Matters

An Interview with Dr. Lawson Macartney, CEO of Ambrx Pharmaceuticals

An interview with Dr. Lawson Macartney, CEO of Ambrx Pharmaceuticals, on the co-development of an ADC therapeutic for HER2-Positive breast for cancer in China.   THE NEWS: This month’s Inside Perspective features Dr. Lawson Macartney, CEO of Ambrx Pharmaceuticals. Ambrx recently announced a deal in which it...

The First True Anti-Aging Drug?

A clinical trial sponsored by Novartis could potentially unlock the secret of the molecular “fountain of youth” and holds the promise of an effective anti-aging drug.  The clinical trial conducted in New Zealand and Australia is a randomized, observer-blind, placebo-controlled trial that enrolled over...

Hydra Biosciences sees TRP Ion Channels as Pathway to Opioid Alternatives

While sky-rocketing death tolls from opioid pain drug addiction in the US have dominated the headlines in recent years, only slim effort has been made to find the alternative, non-habit-forming pain-killers doctors need to treat chronic pain. In fact, only a relative handful of...

A Passion for Precision Medicines: How Three Start-ups Are Changing the Paradigm

By Hui Cai, Vice President of Corporate Alliances and Head of Corporate Communications, WuXi AppTec Troy Wilson jokes about time travel being the basis of his next company, and it’s with good reason. A serial entrepreneur, he has been remarkably productive over the last several years,...

‘Shared’ Pathways to Success: Viela Bio’s Quest to Develop First-in-Class Molecules to Treat High Unmet Medical Needs

By Rich Soll, Senior Advisor, Strategic Initiatives at WuXi AppTec (@richsollwx) Viela Bio, a new spin-out from biotech trailblazer MedImmune, expects to bring new hope to patients who suffer from autoimmune and inflammatory diseases via its robust pipeline of unique molecules.  Armed with a recent...

SPOTLIGHT

STAY CONNECTED

Twitter LinkedIn 

WUXI NEWS

Historic Approvals Highlighted at the Second China Innovative Drug Ecosystem Forum...

The recent China Innovative Drug Ecosystem Forum, organized by STA Pharmaceutical, a WuXi AppTec company (WuXi STA), was a resounding success with apt timing...